Affimed
AFMD
$5.03
Share price
3.07%
Change (1 day)
458.89%
Change (1 year)
Categories
Affimed (AFMD) - Total debt
Total debt on the balance sheet as of September 2023 : $22.26 M
According to Affimed 's latest financial reports the company's total debt is $22.26 M. A company’s total debt is the sum of all current and non-current debts.
Affimed - Total debt on balance sheet (from 2013 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $19.47 M | -7.97% |
| 2021-12-31 | $21.16 M | 1226.88% |
| 2020-12-31 | $1.59 M | -55.32% |
| 2019-12-31 | $3.57 M | -34.62% |
| 2018-12-31 | $5.46 M | -36.56% |
| 2017-12-31 | $8.6 M | 78.12% |
| 2016-12-31 | $4.83 M | -3.43% |
| 2015-12-31 | $5 M | 5.62% |
| 2014-12-31 | $4.73 M | -28.54% |
| 2013-12-31 | $6.62 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $0.71 B | 3,096.63% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $16.59 M | -25.46% | 🇺🇸 USA |
 Agenus
AGEN | $78.01 M | 250.34% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.18 B | 735.71% | 🇺🇸 USA |